PetMed Express (NASDAQ:PETS) Shares Pass Above 200 Day Moving Average – Time to Sell?

PetMed Express, Inc. (NASDAQ:PETS)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.15 and traded as high as $4.82. PetMed Express shares last traded at $4.77, with a volume of 131,466 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.

PetMed Express Trading Down 0.2 %

The business has a 50-day moving average of $5.05 and a 200 day moving average of $4.15. The firm has a market capitalization of $98.56 million, a PE ratio of -79.50 and a beta of 0.69.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.17. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. The business had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. On average, sell-side analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.

Insider Buying and Selling at PetMed Express

In other news, Director Leslie C.G. Campbell bought 15,000 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was acquired at an average cost of $5.38 per share, with a total value of $80,700.00. Following the completion of the transaction, the director now directly owns 70,000 shares of the company’s stock, valued at $376,600. This represents a 27.27 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On PetMed Express

Large investors have recently added to or reduced their stakes in the company. Point72 DIFC Ltd purchased a new stake in shares of PetMed Express during the second quarter worth $34,000. Squarepoint Ops LLC bought a new position in PetMed Express in the 2nd quarter worth about $273,000. Federated Hermes Inc. grew its holdings in PetMed Express by 54.5% during the 2nd quarter. Federated Hermes Inc. now owns 606,430 shares of the company’s stock valued at $2,456,000 after buying an additional 213,903 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of PetMed Express during the second quarter valued at about $797,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of PetMed Express during the second quarter valued at about $135,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.